May. 11 at 12:21 AM
$IBB Q2 2026 Biotech Catalyst Outlook: 88 Major Data Readouts & Regulatory Milestones
We're heading into a serious density of clinical data. If you’re in the trenches with these clinical-stage names, you know the next two months are essentially a gauntlet of binary events.
The schedule is packed: 88 total catalysts, including 26 for May and 20 for June. I’m sharing this for those interested in a clear view of the upcoming calendar. It’s not an exhaustive list of every micro-cap ticker, but it covers the heart of the sector's upcoming volume.
FWIW... trading this sector successfully requires looking past the mainstream narratives. I find it’s best to ignore the surface-level chatter and stick to a disciplined process of clinical and fundamental due diligence. Respect to everyone grinding through the data. Wishing you all the best... may your discipline be rewarded with the outcomes you’ve worked so hard to achieve. 🙏🏻
$XBI $CYTK $PFE $LLY - Source data: BiopharmIQ
